nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Assessing the most accurate formula to predict the risk of lymph node metastases from prostate cancer in contemporary patients treated with radical prostatectomy and extended pelvic lymph node dissection
|
Abdollah, Firas |
|
2013 |
109 |
2 |
p. 211-216 6 p. |
artikel |
2 |
Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial brachytherapy monotherapy
|
Tran, Anna Thi Huyen |
|
2013 |
109 |
2 |
p. 235-240 6 p. |
artikel |
3 |
Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: A prospective, multicenter phase II trail
|
Meng, Xue |
|
2013 |
109 |
2 |
p. 275-280 6 p. |
artikel |
4 |
Chromosome inversions in lymphocytes of prostate cancer patients treated with X-rays and carbon ions
|
Pignalosa, Diana |
|
2013 |
109 |
2 |
p. 256-261 6 p. |
artikel |
5 |
Cold spot mapping inferred from MRI at time of failure predicts biopsy-proven local failure after permanent seed brachytherapy in prostate cancer patients: Implications for focal salvage brachytherapy
|
Crehange, Gilles |
|
2013 |
109 |
2 |
p. 246-250 5 p. |
artikel |
6 |
Contents
|
|
|
2013 |
109 |
2 |
p. v-vi nvt p. |
artikel |
7 |
Editorial Board
|
|
|
2013 |
109 |
2 |
p. ii- 1 p. |
artikel |
8 |
Erratum to “A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone” [Radiother Oncol 108 (2013) 123–127]
|
Rades, Dirk |
|
2013 |
109 |
2 |
p. 335- 1 p. |
artikel |
9 |
HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study
|
Zolciak-Siwinska, Agnieszka |
|
2013 |
109 |
2 |
p. 194-199 6 p. |
artikel |
10 |
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: Early late toxicity and 3-year clinical outcome
|
Fonteyne, Valérie |
|
2013 |
109 |
2 |
p. 229-234 6 p. |
artikel |
11 |
Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: Normal tissue complication probability modeling with latent time correction
|
Rønjom, Marianne Feen |
|
2013 |
109 |
2 |
p. 317-322 6 p. |
artikel |
12 |
Important ESTRO dates
|
|
|
2013 |
109 |
2 |
p. I- 1 p. |
artikel |
13 |
Is there a relation between the radiation dose to the different sub-segments of the lower urinary tract and urinary morbidity after brachytherapy of the prostate with I-125 seeds?
|
Steggerda, Marcel J. |
|
2013 |
109 |
2 |
p. 251-255 5 p. |
artikel |
14 |
Long-term efficacy of fractionated radiotherapy for benign meningiomas
|
Soldà, Francesca |
|
2013 |
109 |
2 |
p. 330-334 5 p. |
artikel |
15 |
Malignant salivary gland tumours: Can fast neutron therapy results point the way to carbon ion therapy?
|
Stannard, Clare |
|
2013 |
109 |
2 |
p. 262-268 7 p. |
artikel |
16 |
Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer
|
Lartigau, Eric F. |
|
2013 |
109 |
2 |
p. 281-285 5 p. |
artikel |
17 |
Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation
|
Ohashi, Toshio |
|
2013 |
109 |
2 |
p. 241-245 5 p. |
artikel |
18 |
Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation
|
Antunes, Heliton S. |
|
2013 |
109 |
2 |
p. 297-302 6 p. |
artikel |
19 |
Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: Toxicity and matched case comparison with postoperative prostate bed-only radiotherapy
|
Van Praet, Charles |
|
2013 |
109 |
2 |
p. 222-228 7 p. |
artikel |
20 |
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study
|
Busetto, Mario |
|
2013 |
109 |
2 |
p. 303-310 8 p. |
artikel |
21 |
Radiologic assessment of retropharyngeal node involvement in oropharyngeal carcinomas stratified by HPV status
|
Tang, Chad |
|
2013 |
109 |
2 |
p. 293-296 4 p. |
artikel |
22 |
Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer
|
Lutkenhaus, Lotte J. |
|
2013 |
109 |
2 |
p. 200-203 4 p. |
artikel |
23 |
Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity
|
Nuyts, Sandra |
|
2013 |
109 |
2 |
p. 323-329 7 p. |
artikel |
24 |
Re-irradiation and hyperthermia after surgery for recurrent breast cancer
|
Linthorst, Marianne |
|
2013 |
109 |
2 |
p. 188-193 6 p. |
artikel |
25 |
Role of minor salivary glands in developing patient-rated xerostomia and sticky saliva during day and night
|
Beetz, Ivo |
|
2013 |
109 |
2 |
p. 311-316 6 p. |
artikel |
26 |
Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation
|
Laban, Simon |
|
2013 |
109 |
2 |
p. 286-292 7 p. |
artikel |
27 |
Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
|
King, Christopher R. |
|
2013 |
109 |
2 |
p. 217-221 5 p. |
artikel |
28 |
The effect of induction chemotherapy on tumor volume and organ-at-risk doses in patients with locally advanced oropharyngeal cancer
|
Doornaert, Patricia |
|
2013 |
109 |
2 |
p. 269-274 6 p. |
artikel |
29 |
The heat is (still) on – The past and future of hyperthermic radiation oncology
|
Overgaard, Jens |
|
2013 |
109 |
2 |
p. 185-187 3 p. |
artikel |
30 |
The prostate cancer risk stratification (ProCaRS) project: Recursive partitioning risk stratification analysis
|
Rodrigues, George |
|
2013 |
109 |
2 |
p. 204-210 7 p. |
artikel |